These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11748202)

  • 1. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
    Krall R; Sun J; Pederson KJ; Barbieri JT
    Infect Immun; 2002 Jan; 70(1):360-7. PubMed ID: 11748202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    Goehring UM; Schmidt G; Pederson KJ; Aktories K; Barbieri JT
    J Biol Chem; 1999 Dec; 274(51):36369-72. PubMed ID: 10593930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
    Pederson KJ; Krall R; Riese MJ; Barbieri JT
    Mol Microbiol; 2002 Dec; 46(5):1381-90. PubMed ID: 12453223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa ExoT acts in vivo as a GTPase-activating protein for RhoA, Rac1, and Cdc42.
    Kazmierczak BI; Engel JN
    Infect Immun; 2002 Apr; 70(4):2198-205. PubMed ID: 11895987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
    Maresso AW; Baldwin MR; Barbieri JT
    J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
    Maresso AW; Riese MJ; Barbieri JT
    Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells.
    Pederson KJ; Pal S; Vallis AJ; Frank DW; Barbieri JT
    Mol Microbiol; 2000 Jul; 37(2):287-99. PubMed ID: 10931325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS.
    Maresso AW; Barbieri JT
    Protein Expr Purif; 2002 Dec; 26(3):432-7. PubMed ID: 12460767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific roles of the GTPase activating protein Nadrin in cytoskeletal reorganization of platelets.
    Beck S; Fotinos A; Lang F; Gawaz M; Elvers M
    Cell Signal; 2013 Jan; 25(1):236-46. PubMed ID: 22975681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
    Zhang Y; Deng Q; Porath JA; Williams CL; Pederson-Gulrud KJ; Barbieri JT
    Cell Microbiol; 2007 Sep; 9(9):2192-201. PubMed ID: 17490406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
    Krall R; Zhang Y; Barbieri JT
    J Biol Chem; 2004 Jan; 279(4):2747-53. PubMed ID: 14597627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.
    Zhang Y; Deng Q; Barbieri JT
    J Biol Chem; 2007 Apr; 282(17):13022-32. PubMed ID: 17311921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.